DEBRA Research, LEO Pharma Partner to Advance Treatments for EB
DEBRA Research GmbH, a non-profit organization focused on advancing research, advocacy, and support for those affected by Epidermolysis Bullosa (EB), and LEO Pharma are partnering to accelerate the development of new therapies for EB. There are currently no approved treatment options for EB. “We are pleased to announce our non-exclusive partnership with LEO Pharma, which […]